AskNiveshLive·10:38 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to AUROPHARMA

Aurobindo Pharma Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
8,3827,8688,2868,6468,853
Other income
135105121188117
Expenses
7,1506,7697,1327,4307,677
Cost of materials consumed
2,8002,5352,5102,7552,505
Purchases of stock-in-trade
636808846893931
Change in inventories
-8-104-17-166-8
Employee benefit expense
1,1631,2291,2771,3101,374
Finance costs
11598959398
Depreciation & amortisation
444406429465479
Other expenses
2,0001,7971,9912,0812,298
EBITDA
1,9261,7091,7981,8961,870
EBIT
1,4821,3031,3691,4311,391
Exceptional items
----65-
Profit Before Tax
1,3671,2051,2741,3381,293
Tax expense
432383428429370
Deferred tax
2-108-3545-29
Net Profit
903824848910921
Financial Ratios
Operating Profit Margin
17.68%16.56%16.52%16.55%15.71%
EBITDA Margin
22.98%21.72%21.70%21.93%21.13%
Net Profit Margin
10.77%10.47%10.23%10.53%10.40%
Earnings Per Share (₹)
15.5614.2014.6115.6715.86

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.